Leveraging proteomics in orphan disease research: pitfalls and potential

Area of Science:

• Biochemistry
• Bioinformatics
• Genetics

Background:

• Rare diseases affect small populations, posing challenges for drug development due to commercial viability concerns.
• Proteomics provides insights into disease mechanisms, biomarkers, and therapeutic intervention effects for rare conditions.
• Existing research in rare diseases faces hurdles, necessitating specialized collaborative frameworks.

Purpose of the Study:

• To review the application of proteomics and bioinformatic tools in rare disease research.
• To discuss the potential and challenges of using these technologies in the field.
• To highlight the role of omics technologies in advancing precision medicine for rare diseases.

Main Methods:

• Literature review of proteomics and bioinformatics applications in rare diseases.
• Analysis of challenges and opportunities in rare disease research.
• Discussion of data integration and collaborative approaches.

Main Results:

• Proteomics offers valuable data on rare disease pathophysiology, biomarker discovery, and treatment response.
• Bioinformatic tools are crucial for analyzing complex omics data in rare diseases.
• Collaborative consortia and data sharing are essential for progress.

Conclusions:

• The integration of proteomics and bioinformatics is pivotal for understanding rare disease pathophysiology.
• Rare disease characteristics, like limited patient numbers and registries, can be leveraged for precision medicine.
• Multidisciplinary collaboration and advanced technologies are key to accelerating rare disease research and drug development.